Zoster Vaccine Live
ApprovedCompleted 0 views this week 0 watching⚡ Active
Interest: 43/100
43
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Herpes Zoster
Conditions
Herpes Zoster, Shingles
Trial Timeline
Apr 1, 2012 → Oct 1, 2012
NCT ID
NCT01556451About Zoster Vaccine Live
Zoster Vaccine Live is a approved stage product being developed by Merck for Herpes Zoster. The current trial status is completed. This product is registered under clinical trial identifier NCT01556451. Target conditions include Herpes Zoster, Shingles.
What happened to similar drugs?
4 of 20 similar drugs in Herpes Zoster were approved
Approved (4) Terminated (1) Active (15)
Hype Score Breakdown
Clinical
20
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (3)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02624375 | Approved | Completed |
| NCT01527370 | Phase 3 | Completed |
| NCT01556451 | Approved | Completed |
Competing Products
20 competing products in Herpes Zoster